Maintaining Study Patient Engagement During the COVID-19 Emergency

The COVID-19 pandemic has caused an enormous disruption in healthcare priorities and staffing, and as restrictions on people’s movement have increased, clinical research sites face unprecedented challenges to adjust studies and patient engagement accordingly. The FDA has provided guidance to support ongoing continuity and response efforts, wherein the safety of trial participants is paramount. It […]


Clinical Trial Retention Strategies During a Crisis

Research organizations worldwide are working to quickly adapt their clinical trials to the realities that COVID-19 has brought. Investigators and study staff are handling increased administrative burdens, as well as dealing with the ever-changing guidelines and patient questions. Below are some best practices for how to retain current patients during the midst of a medical […]


Recruitment Strategies in the COVID-19 Era

As studies adapt to the new reality, how will they recruit patients effectively? Recruiting in the era of COVID-19 will not be easy, but it can be done. To ensure patient safety, there is a growing need to modify protocols, establish new remote procedures and implement exposure risk-mitigation measures for sites to continue running clinical […]


Investigator Initiated Trials: Common Recruitment Oversights & Effective Corrective Actions

One of the biggest challenges in launching an IIT is securing enough study participants. While many university clinic offices might have an affiliation with the local health system and can recruit patients directly, depending on the condition or treatment, they still need to focus on recruitment efforts for successful trial execution. For example, a 2019 […]


Essential COVID-19 Communications for Your Site

COVID-19 is spreading rapidly, and its effects are creating many new challenges for clinical trials. Sites are being forced to reevaluate their procedures to protect participant safety and ensure continued engagement so trials can continue running. With so many changes occurring, continuous communication with all parties involved in the clinical trial is critical so that […]


AI is Revolutionizing Trial Recruitment

Of all the barriers to success in clinical trials, recruitment is arguably the biggest. It is a slow and expensive part of the process, one that can stretch on months or even years longer than planned. The vast majority of clinical trials fail to meet enrollment deadlines. A 2018 study estimated that 20 percent of […]


Investigator Initiated Trials: Common Quality Oversights & Effective Corrective Actions

Many factors can influence the quality of a clinical trial. Those that follow good clinical practice (GCP) adhere to universal scientific and ethical quality standards. Successful trials develop a system of tracking quality issues through all stages of the study—design, conducting, recording and reporting. Trials that don’t may run into delays and compliance issues that […]


Make Technology Part of Your Patient Retention Toolbox

While patient outreach efforts often focus on study recruitment, patient retention should also be a top goal for your communication plans.. In fact, retention might even be a more critical element as it is the component most likely to ensure your trial moves through its phases smoothly. Drop out rates for long-term Phase 3 trials […]


Investigator Initiated Trials: Common Budget Oversights and Effective Corrective Actions

When you’re about to embark on the important work of a research trial, the last thing you want to worry about is money. But your trial may be cut short—or fail to launch altogether—if your resources don’t meet the needs of the investigation. Investigator Initiated Trials need the same financial planning, diligence, and oversight as […]


Overcoming Institutional Barriers to Cancer Trial Enrollment

Did you know that out of  all patients with a cancer diagnosis, only 8% will ever be enrolled in a clinical trial?  Whether there are no trials available close to the patient’s location, the patient is not eligible, or they were never asked to participate, the barriers to cancer patient enrollment are one of the […]